| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/04/2009 | CN100464767C A medicine composition for treating hyperuricemia |
| 03/04/2009 | CN100464765C A preparation method of constipation relieving powders |
| 03/04/2009 | CN100464763C Chinese medicinal incense used for preventing infectious diseases and a making method thereof |
| 03/04/2009 | CN100464759C Anticancer Chinese traditional extracts and a preparation process and an application thereof |
| 03/04/2009 | CN100464756C An application of fucoidan in the preparation of medicines and health-care products for preventing and treating neurodegenerative diseases |
| 03/04/2009 | CN100464754C Acarbose medicine compositions and a preparation method thereof |
| 03/04/2009 | CN100464752C Granisetron cataplasm and a preparation method thereof |
| 03/04/2009 | CN100464751C Matrine eye drip liquid and a production method thereof |
| 03/04/2009 | CN100464750C A method for preparing medicinal compounds with amoxicillin sodium and potassium clavulanate |
| 03/04/2009 | CN100464749C 5HT4 partial agonist pharmaceutical compositions |
| 03/04/2009 | CN100464747C A medicine composition with bailobalide |
| 03/04/2009 | CN100464745C A medication composition of acetyl cysteine or a pharmaceutical salt thereof and asarin |
| 03/04/2009 | CN100464744C An orally disintegrated Ubenimex tablet and a preparation method thereof |
| 03/04/2009 | CN100464741C An aqueous-alcoholic depigmenting gel with phenolic derivatives and the vitamer A |
| 03/04/2009 | CN100464740C An osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and a preparation method thereof |
| 03/04/2009 | CN100464739C A dispersion tablets used as gynecologic hemostatic and a preparation method thereof |
| 03/04/2009 | CN100464738C A production method of pharmaceutical solid preparation with poorly soluble drugs |
| 03/04/2009 | CN100464737C A medicinal composition of nimustine and a synergist thereof |
| 03/04/2009 | CN100464736C A slow released anticancer injection with both antimetabolite and a synergist thereof |
| 03/04/2009 | CN100464735C A preparation method of hydro-acupuncture of liver cell growth promoting factors |
| 03/04/2009 | CN100464734C A desensitizing anticarious gel and a preparation method thereof |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | US7498309 Containing a suspending agent (oleoyl macrogol glyceride), and a dispersant (silica sol); treating intestinal bowel disease, Crohn's disease, or colitis, or inflammatory conditions resulting from cytoablative treatment or HIV infection. |
| 03/03/2009 | US7498303 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
| 03/03/2009 | US7498045 Biodegradable polymeric nanocapsules and uses thereof |
| 03/03/2009 | US7498044 Dosage form and method for producing the same |
| 03/03/2009 | US7498043 Silicon substituted oxyapatite |
| 03/03/2009 | US7498041 Composition for repair of defects in osseous tissues |
| 03/03/2009 | US7498040 Compositions for repair of defects in osseous tissues, and methods of making the same |
| 03/03/2009 | US7498039 Nutritional supplement containing sea water minerals |
| 03/03/2009 | US7498038 Chitin microparticles and their medical uses |
| 03/03/2009 | US7498035 conjugates of methoxylpolyethylene glycol-glutamic acid oligopeptide and drug such as antitumor agents, having low toxicity, improved solubility, sustain and/or control release profiles |
| 03/03/2009 | US7498020 Medicaments |
| 03/03/2009 | US7498019 Delivery of compounds for the treatment of headache through an inhalation route |
| 03/03/2009 | US7497910 Dry powder electrostatic deposition method and apparatus |
| 03/03/2009 | US7497856 Arrangement for remote-controlled release of active ingredients |
| 03/03/2009 | US7497855 Method and device for the controlled delivery of parathyroid hormone |
| 03/03/2009 | US7497846 Hermetically sealed microchip reservoir devices |
| 03/03/2009 | CA2433773C Low profile pivoting joint infusion assembly |
| 03/03/2009 | CA2433714C Arthritis preventing or treating agent |
| 03/03/2009 | CA2356197C Thin polymer film drug reservoirs |
| 03/03/2009 | CA2324904C Topical hormonal composition with systemic effect |
| 03/03/2009 | CA2314173C Therapeutic uses of gaseous mixtures of helium and oxygen, in particular in the treatment of asthma |
| 03/03/2009 | CA2280089C Compositions and methods for reducing ocular hypertension |
| 03/03/2009 | CA2270286C Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 02/27/2009 | CA2599082A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds |
| 02/26/2009 | WO2009026461A2 Thermo-kinetic mixing for pharmaceutical applications |
| 02/26/2009 | WO2009026430A2 Liposome formulations of boronic acid compounds |
| 02/26/2009 | WO2009026427A2 Liposome compositions for in vivo administration of boronic acid compounds |
| 02/26/2009 | WO2009026414A2 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 02/26/2009 | WO2009026368A2 Composition and method for managing blood glucose levels, insulin levels and/or insulin receptor functionality |
| 02/26/2009 | WO2009026315A2 Use of carbon nanotube for drug delivery |
| 02/26/2009 | WO2009026257A2 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 02/26/2009 | WO2009026251A1 Detecting ions and measuring ion concentrations |
| 02/26/2009 | WO2009026178A2 High concentration local anesthetic formulations |
| 02/26/2009 | WO2009026135A2 Controlled transdermal bisoprolol delivery system |
| 02/26/2009 | WO2009026133A2 Transdermal bisoprolol delivery system |
| 02/26/2009 | WO2009026115A1 Palatable microgranules for acidifying feed rations |
| 02/26/2009 | WO2009026103A1 Method and arrangement for forming variable color pharmaceutical products |
| 02/26/2009 | WO2009025859A1 Paliperidone sustained release formulation |
| 02/26/2009 | WO2009025820A2 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 02/26/2009 | WO2009025802A1 Copolymer-stabilized emulsions |
| 02/26/2009 | WO2009025782A2 Hemostatic agent composition and method of delivery |
| 02/26/2009 | WO2009025777A1 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 02/26/2009 | WO2009025576A1 Method for producing the micronised powder of encapsulated organic medicinal substance having a slow water solubility |
| 02/26/2009 | WO2009025571A1 Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease |
| 02/26/2009 | WO2009025372A1 Composition containing reduced coenzyme q10, and method for stabilizing the composition |
| 02/26/2009 | WO2009025315A1 Oral preparation for improvement of bioavailability of curcumin |
| 02/26/2009 | WO2009025277A1 Method of producing reduced coenzyme q10 and method of stabilizing the same |
| 02/26/2009 | WO2009025239A1 Novel preparation for external use |
| 02/26/2009 | WO2009025168A1 Sugar-modified liposome containing compound for contrast agent and contrast agent |
| 02/26/2009 | WO2009024992A2 Film coating compositions based on tribasic calcium phosphate |
| 02/26/2009 | WO2009024957A1 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 02/26/2009 | WO2009024858A1 Controlled release dosage form of galantamine |
| 02/26/2009 | WO2009024797A1 Glucagon formulations |
| 02/26/2009 | WO2009024795A1 Acid containing lipid formulations |
| 02/26/2009 | WO2009024686A2 Novel method for producing dry hydrodispersible pharmaceutical forms |
| 02/26/2009 | WO2009024670A2 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/26/2009 | WO2009024635A1 Organic-inorganic hybrid material for storage and release of active principles |
| 02/26/2009 | WO2009024590A2 Antifungal composition |
| 02/26/2009 | WO2009024535A1 Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics |
| 02/26/2009 | WO2009024376A1 Microcapsule and method for the production thereof |
| 02/26/2009 | WO2009024087A1 An uv-assisted method for surface modification and products having surface formed thereby |
| 02/26/2009 | WO2009024015A1 A stable formulation of exenatide |
| 02/26/2009 | WO2009009622A3 Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| 02/26/2009 | WO2009009620A3 Acellular tissue matrix compositions for tissue repair |
| 02/26/2009 | WO2009004654A3 Modified release dosage form of sulfonylurea compound |
| 02/26/2009 | WO2009002084A3 Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same |
| 02/26/2009 | WO2008156217A3 Pharmaceutical solid preparation comprising benzazepines and production method thereof |
| 02/26/2009 | WO2008144690A3 Compositions and methods for enhancing active agent absorption |
| 02/26/2009 | WO2008135361A3 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
| 02/26/2009 | WO2008119943A3 Enteric pharmaceutical capsules |
| 02/26/2009 | WO2008102144A3 Aqueous formulations |
| 02/26/2009 | WO2008088581A3 Liposome treatment of viral infections |
| 02/26/2009 | WO2008086844A3 Co-precipitate, method for preparing the same and uses thereof |
| 02/26/2009 | WO2008071407A3 Coated pellets |
| 02/26/2009 | WO2008051527A3 Sustained release of agents for localized pain management |
| 02/26/2009 | WO2008036117A3 Nanogel contrast agents for optical molecular imaging |
| 02/26/2009 | WO2008015530A3 Stable solid oral formulation of pantoprazole |